Suchergebnisse - "Lu, Hui-Ping"

PubPharm (48)

1

Clinical significance and prospective mechanism of increased CDKN2A expression in small cell lung cancer

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2024

von Li, D. | Li, G. | Li, J. | +10

2

Clinical Implication of E2F Transcription Factor 1 in Hepatocellular Carcinoma Tissues

enthalten in: Cancer biotherapy & radiopharmaceuticals | 2023

von Ye, W. | Lu, H. | Li, J. | +11

3

A high-throughput screening campaign against PFKFB3 identified potential inhibitors with novel scaffolds

enthalten in: Acta pharmacologica Sinica | 2023

von Li, J. | Zhou, Y. | Eelen, G. | +9

4

Prognostic Signature and Discrimination Signature of Lung Adenocarcinoma based on Pyroptosis-Related Genes

enthalten in: Combinatorial chemistry & high throughput screening | 2023

von Li, G. | Lu, H. | Gao, L. | +10

5

MMP12 serves as an immune cell-related marker of disease status and prognosis in lung squamous cell carcinoma

enthalten in: PeerJ | 2023

von Zhang, W. | Li, G. | Gan, X. | +13

6

Downregulation of zinc finger protein 71 in laryngeal squamous cell carcinoma tissues and its potential molecular mechanism and clinical significance : a study based on immunohistochemistry staining and data mining

enthalten in: World journal of surgical oncology | 2022

von Jiang, F. | Luo, J. | Dang, Y. | +12

7

Downregulation of zinc finger protein 71 in laryngeal squamous cell carcinoma tissues and its potential molecular mechanism and clinical significance: a study based on immunohistochemistry staining and data mining

enthalten in: World journal of surgical oncology | 2022

von Jiang, F. | Luo, J. | Dang, Y. | +12

8

The effect of lexical tone experience on English intonation perception in Mandarin-speaking cochlear-implanted children

enthalten in: Medicine | 2022

von Lu, H. | Lin, C. | Wu, C. | +3

9

SYNJ2 is a novel and potential biomarker for the prediction and treatment of cancers : from lung squamous cell carcinoma to pan-cancer

enthalten in: BMC medical genomics | 2022

von Hou, W. | Li, G. | Gao, L. | +6

10

SYNJ2 is a novel and potential biomarker for the prediction and treatment of cancers: from lung squamous cell carcinoma to pan-cancer

enthalten in: BMC medical genomics | 2022

von Hou, W. | Li, G. | Gao, L. | +6

1
2
3
4
5
Nächster »
[5]